| Name: |
|
| Other Names: |
|
|
Classification:
|
|
|
Mechanism of Action:
|
- Stimulates the β1 receptors in the heart resulting in increased cardiac output
- Increases contractility without inducing marked tachycardia (positive Inotrope)
- Increases stroke volume
- Some increase in heart rate (positive Chronotrope)
- Decreased systemic vascular resistance
- Reduces ventricular filling pressure
|
|
Indications:
|
- Decreased heart function due to cardiac contractility
- Systolic BP 70 – 100 mmHg with no signs of shock
|
|
Contraindications:
|
- Untreated hypovolemia
- Vasodilatory shock (septic, neurogenic, anaphylactic). Dobutamine can cause further vasodilatation and worsen hypotension in these patients
|
|
Precautions:
|
- Monitor EKG
- Monitor BP at least every 2-5min while initiating and titrating
- Use caution in patients with tachycardia or ventricular ectopy, as dobutamine potentiates both, but less than dopamine does
- Patients should be adequately hydrated
- Beta blockers may antagonize dobutamine effects. Do not use together
- Don’t use with Sodium Bicarbonate (will deactivate the medication)
- Allergic cross reaction in those with sulfite allergies
|
|
Adverse Effects:
|
- May increase myocardial ischemia
- Headache
- Hypertension
- Palpitations
|
|
Dose:
|
|
|
Adult:
|
- Start 2.5 - 5 mcg/kg/min IV; titrate for SBP > 90 up to 20 mcg/kg/min. For BP < 90 may need to start with dopamine then add dobutamine, or if BP drops initially add dopamine
|
|
Pediatric:
|
|
| Routes: |
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Professional 2nd Edition
|
Last modified: Sunday, 16 March 2025, 3:31 PM